LivaNova PLC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LivaNova PLC on January 5, 2016, regarding events occurring on December 31, 2015. The Company is a medical device manufacturer incorporated in England and Wales.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, or debt figures. However, management estimates that less than 1% of 2016 consolidated sales could be impacted by the regulatory event described below.
Material Changes and Regulatory Events
- FDA Warning Letter: On December 29, 2015, the U.S. Food and Drug Administration (FDA) issued a Warning Letter alleging violations of regulations at the Company's Munich, Germany, and Arvada, Colorado facilities.
- Inspection History: The FDA inspected the Munich facility (August 24–27, 2015) and issued a Form 483 citing two non-conformities. The Arvada facility was inspected (August 24–September 1, 2015) without a Form 483 being issued.
- Import Alert: The Warning Letter states that 3T Heater Cooler devices and other devices from the Munich facility are subject to refusal of admission into the United States until issues are resolved. The import alert is currently limited to 3T Heater Cooler devices.
- Operational Impact: Manufacturing and shipment of all products other than the 3T Heater Cooler are unaffected. The FDA did not request that existing users cease using the 3T Heater Cooler device.
Management Commentary, Risks, and Outlook
Management believes the FDA's concerns can be resolved without a material impact on the Company's financial results. The Company is planning further meetings with the FDA to clarify aspects of the Warning Letter and is working to remediate inspectional observations. While the Warning Letter notes that premarket approval applications for Class III devices related to Quality System regulation deviations will not be approved until violations are corrected, the Company notes that the named facilities do not manufacture or design devices subject to premarket approval.
Key Facts for Investor Verification
- Verify the scope of the FDA import alert regarding 3T Heater Cooler devices and potential expansion to other products.
- Monitor the timeline for resolution of the Warning Letter and the impact on the less than 1% of 2016 sales at risk.
- Confirm that the Munich and Arvada facilities do not manufacture Class III devices requiring premarket approval, as stated by management.
- Review the Company's corrective and preventive action plan submitted to the FDA.